Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Artiva Biotherapeutics (ARTV) Other Non-Current Assets (2023 - 2025)

Historic Other Non-Current Assets for Artiva Biotherapeutics (ARTV) over the last 3 years, with Q3 2025 value amounting to $461000.0.

  • Artiva Biotherapeutics' Other Non-Current Assets rose 7868.22% to $461000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $461000.0, marking a year-over-year increase of 7868.22%. This contributed to the annual value of $267000.0 for FY2024, which is 3188.78% down from last year.
  • As of Q3 2025, Artiva Biotherapeutics' Other Non-Current Assets stood at $461000.0, which was up 7868.22% from $461000.0 recorded in Q2 2025.
  • In the past 5 years, Artiva Biotherapeutics' Other Non-Current Assets registered a high of $461000.0 during Q1 2025, and its lowest value of $258000.0 during Q2 2023.
  • Moreover, its 3-year median value for Other Non-Current Assets was $262500.0 (2023), whereas its average is $333200.0.
  • Per our database at Business Quant, Artiva Biotherapeutics' Other Non-Current Assets tumbled by 3188.78% in 2024 and then surged by 7868.22% in 2025.
  • Artiva Biotherapeutics' Other Non-Current Assets (Quarter) stood at $392000.0 in 2023, then plummeted by 31.89% to $267000.0 in 2024, then skyrocketed by 72.66% to $461000.0 in 2025.
  • Its last three reported values are $461000.0 in Q3 2025, $461000.0 for Q2 2025, and $461000.0 during Q1 2025.